In addition, qRT-PCR and western blotting showed that the expression of GSCs marker CD133 and pluripotency factors including SOX2, OCT4 and NANOG were upregulated proportionally in GBM cells treated with increasing HMGB1 concentrations (Figures 3C,D). This evidence concerns the gene PROM1 and glioblastoma.